That headline is not in my words, of course (that’s why I use those handy little quotation marks), but it’s the headline from the latest Nick Hodge ad that’s been getting a lot of attention from Gumshoe readers. Hodge is pitching this new device, which apparently faces a big moment on June 30, as a […]
Articles
Stansberry Venture is a high-end ($5,000/yr) newsletter that focuses on small “breakthrough” type companies, so far mostly in biotech and technology as far as I’ve seen. It’s the heir, roughly speaking, of Stansberry’s old Phase 1 newsletter that used to often pitch biotech, tech and junior mining stocks. It’s helmed by Dave Lashmet, who was […]
The latest screed from Danielle O’Dell for the Money Map Report is aimed at first getting you all fired up about Obamacare, in case you’re one of the seven people in the United States that doesn’t already have a strong opinion about that law’s impending enactment, and then, more importantly, at telling you that she’s […]
Patrick Cox has found a new home — he has issued many a tempting teaser campaign over the years, and I was wondering what had happened to him after leaving his Breakthrough Technology Alert in the hands of Ray Blanco this Summer. Well, I can stop wondering — he jumped to a new publisher and […]
And we’re back! Today, it’s a biotech teaser from Brian Hicks for Steve Christ’s The Wealth Advisory (we last looked at one of his a few months back, when he was predicting a big move in Geron by this Spring — that one’s still on the clock, so we’ll see). This time the tease is […]
Comments
$ONCS reduced to skeletal 20180124 - When the geauxing gets tough, the tough get geauxing.... $ARTH ow, $INO sp - I...